{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:59:51Z","timestamp":1792724391661,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/nrneurol.2010.72","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T12:45:11Z","timestamp":1278506711000},"page":"383-392","source":"Crossref","is-referenced-by-count":380,"title":["AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance"],"prefix":"10.1038","volume":"6","author":[{"given":"Sven","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrneurol201072_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk, D. M., Hogancamp, W. F., O'Brien, P. C. & Weinshenker, B. G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53, 1107\u20131114 (1999).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","volume":"197","author":"J de Seze","year":"2002","unstructured":"de Seze, J.  et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J. Neurol. Sci. 197, 57\u201361 (2002).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201072_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius, S.  et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat. Clin. Pract. Neurol. 4, 202\u2013214 (2008).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"BFnrneurol201072_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti, C. F.  et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125, 1450\u20131461 (2002).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker, B. G.  et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 46, 878\u2013886 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201072_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M Keegan","year":"2002","unstructured":"Keegan, M.  et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58, 143\u2013146 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon, V. A.  et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106\u20132112 (2004).","journal-title":"Lancet"},{"key":"BFnrneurol201072_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic\u2013spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473\u2013477 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol201072_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer, S. F.  et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130, 1194\u20131205 (2007).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu, T.  et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130, 1224\u20131234 (2007).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker, B. G.  et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 59, 566\u2013569 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201072_CR12","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello, M.  et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70, 2197\u20132200 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi, T.  et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130, 1235\u20131243 (2007).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR14","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"S Jarius","year":"2008","unstructured":"Jarius, S.  et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131, 3072\u20133080 (2008).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1352458508100837","volume":"15","author":"M Bonnan","year":"2009","unstructured":"Bonnan, M.  et al. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult. Scler. 15, 487\u2013492 (2009).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1352458506071174","volume":"13","author":"S Watanabe","year":"2007","unstructured":"Watanabe, S.  et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult. Scler. 13, 128\u2013132 (2007).","journal-title":"Mult. Scler."},{"issue":"Suppl. 3","key":"BFnrneurol201072_CR17","first-page":"A187","volume":"72","author":"I Nakashima","year":"2009","unstructured":"Nakashima, I.  et al. Plasma exchange for neuromyelitis optica with aquaporin-4 antibody [abstract P04.092]. Neurology 72 (Suppl. 3), A187 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR18","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree, B. A.  et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64, 1270\u20131272 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR19","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","volume":"65","author":"A Jacob","year":"2008","unstructured":"Jacob, A.  et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch. Neurol. 65, 1443\u20131448 (2008).","journal-title":"Arch. Neurol."},{"issue":"Suppl. 3","key":"BFnrneurol201072_CR20","first-page":"A189","volume":"72","author":"GS Bedi","year":"2009","unstructured":"Bedi, G. S., Brown, A., Delgado, S., Usmani, N. & Sheremata, W. Effect of rituximab on relapse rate and disability in neuromyelitis optica (NMO) [abstract P04.099]. Neurology 72 (Suppl. 3), A189 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jns.2008.08.015","volume":"276","author":"K Heerlein","year":"2009","unstructured":"Heerlein, K.  et al. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J. Neurol. Sci. 276, 184\u2013186 (2009).","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 3","key":"BFnrneurol201072_CR22","first-page":"A281","volume":"72","author":"C Suzuki","year":"2009","unstructured":"Suzuki, C.  et al. Anti-aquaporin-4 antibody production from peripheral B cells in neuromyelitis optica [abstract S39.005]. Neurology 72 (Suppl. 3), A281 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ana.20890","volume":"59","author":"E Meinl","year":"2006","unstructured":"Meinl, E., Krumbholz, M. & Hohlfeld, R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 59, 880\u2013892 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201072_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-006-0169-2","volume":"113","author":"C Sinclair","year":"2007","unstructured":"Sinclair, C., Kirk, J., Herron, B., Fitzgerald, U. & McQuaid, S. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. (Berl.) 113, 187\u2013194 (2007).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BFnrneurol201072_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1620\/tjem.209.269","volume":"209","author":"T Misu","year":"2006","unstructured":"Misu, T.  et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J. Exp. Med. 209, 269\u2013275 (2006).","journal-title":"Tohoku J. Exp. Med."},{"key":"BFnrneurol201072_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun, S.  et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133, 349\u2013361 (2010).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR27","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1212\/WNL.0b013e3181c1deb9","volume":"73","author":"K Yanagawa","year":"2009","unstructured":"Yanagawa, K.  et al. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology 73, 1628\u20131637 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR28","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/archneurol.2009.199","volume":"66","author":"N Kale","year":"2009","unstructured":"Kale, N.  et al. Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis optica IgG. Arch. Neurol. 66, 1298\u20131299 (2009).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201072_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","volume":"80","author":"T Misu","year":"2009","unstructured":"Misu, T.  et al. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J. Neurol. Neurosurg. Psychiatry 80, 575\u2013577 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201072_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/01.wnl.0000256820.26489.17","volume":"68","author":"I Miyazawa","year":"2007","unstructured":"Miyazawa, I.  et al. High CSF neurofilament heavy chain levels in neuromyelitis optica. Neurology 68, 865\u2013867 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR31","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","volume":"256","author":"A Uzawa","year":"2009","unstructured":"Uzawa, A.  et al. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J. Neurol. 256, 2082\u20132084 (2009).","journal-title":"J. Neurol."},{"key":"BFnrneurol201072_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0b013e3181c919ee","volume":"74","author":"K Okada","year":"2010","unstructured":"Okada, K., Matsushita, T., Kira, J. & Tsuji, S. B-cell activating factor of the TNF family is upregulated in neuromyelitis optica. Neurology 74, 177\u2013178 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/00207450903428970","volume":"120","author":"S Icoz","year":"2010","unstructured":"Icoz, S.  et al. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int. J. Neurosci. 120, 71\u201375 (2010).","journal-title":"Int. J. Neurosci."},{"key":"BFnrneurol201072_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1590\/S0004-282X2008000500013","volume":"66","author":"SV Alves-Leon","year":"2008","unstructured":"Alves-Leon, S. V.  et al. Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica. Arq. Neuropsiquiatr. 66, 678\u2013684 (2008).","journal-title":"Arq. Neuropsiquiatr."},{"key":"BFnrneurol201072_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1177\/1352458509104595","volume":"15","author":"T Matsushita","year":"2009","unstructured":"Matsushita, T.  et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult. Scler. 15, 834\u2013847 (2009).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR36","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1212\/01.WNL.0000148481.80152.BF","volume":"63","author":"J Correale","year":"2004","unstructured":"Correale, J. & Fiol, M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 63, 2363\u20132370 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR37","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson, S. R.  et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69, 2221\u20132231 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR38","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","volume":"181","author":"T Vincent","year":"2008","unstructured":"Vincent, T.  et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood\u2013brain barrier permeability and granulocyte recruitment. J. Immunol. 181, 5730\u20135737 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneurol201072_CR39","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20081241","volume":"205","author":"SR Hinson","year":"2008","unstructured":"Hinson, S. R.  et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J. Exp. Med. 205, 2473\u20132481 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol201072_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbrc.2010.02.157","volume":"394","author":"M Kinoshita","year":"2010","unstructured":"Kinoshita, M.  et al. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem. Biophys. Res. Commun. 394, 205\u2013210 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol201072_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNR.0b013e3282f2b4eb","volume":"19","author":"J Zhou","year":"2008","unstructured":"Zhou, J.  et al. Altered blood\u2013brain barrier integrity in adult aquaporin-4 knockout mice. Neuroreport 19, 1\u20135 (2008).","journal-title":"Neuroreport"},{"key":"BFnrneurol201072_CR42","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/1352458509106613","volume":"15","author":"T Matsushita","year":"2009","unstructured":"Matsushita, T.  et al. Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult. Scler. 15, 1113\u20131117 (2009).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2006.09.008","volume":"34","author":"XN Zeng","year":"2007","unstructured":"Zeng, X. N.  et al. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol. Cell. Neurosci. 34, 34\u201339 (2007).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFnrneurol201072_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","volume":"24","author":"C Matute","year":"2001","unstructured":"Matute, C.  et al. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24, 224\u2013230 (2001).","journal-title":"Trends Neurosci."},{"key":"BFnrneurol201072_CR45","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1523\/JNEUROSCI.3780-05.2006","volume":"26","author":"E Alberdi","year":"2006","unstructured":"Alberdi, E.  et al. Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J. Neurosci. 26, 3220\u20133228 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201072_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archneur.65.7.913","volume":"65","author":"P Waters","year":"2008","unstructured":"Waters, P.  et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch. Neurol. 65, 913\u2013919 (2008).","journal-title":"Arch. Neurol."},{"issue":"Suppl. 3","key":"BFnrneurol201072_CR47","first-page":"A189","volume":"72","author":"SR Kalluri","year":"2009","unstructured":"Kalluri, S. R.  et al. A novel bio-assay to determine and characterize the antibodies to aquaporin-4 [abstract P04.102]. Neurology 72 (Suppl. 3), A189 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR48","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1177\/1352458509104595","volume":"15","author":"T Matsushita","year":"2009","unstructured":"Matsushita, T.  et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult. Scler. 15, 834\u2013847 (2009).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0165-5728(96)00136-1","volume":"71","author":"OB Spiller","year":"1996","unstructured":"Spiller, O. B., Moretto, G., Kim, S. U., Morgan, B. P. & Devine, D. V. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression. J. Neuroimmunol. 71, 97\u2013106 (1996).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201072_CR50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/WNR.0b013e32832776f4","volume":"20","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita, M.  et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport 20, 508\u2013512 (2009).","journal-title":"Neuroreport"},{"key":"BFnrneurol201072_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","volume":"215","author":"L Sabater","year":"2009","unstructured":"Sabater, L.  et al. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J. Neuroimmunol. 215, 31\u201335 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201072_CR52","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1001\/archneurol.2009.188","volume":"66","author":"SR Hinson","year":"2009","unstructured":"Hinson, S. R.  et al. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch. Neurol. 66, 1164\u20131167 (2009).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201072_CR53","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1352458508099139","volume":"15","author":"H Doi","year":"2009","unstructured":"Doi, H.  et al. Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult. Scler. 15, 304\u2013310 (2009).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR54","doi-asserted-by":"crossref","unstructured":"Jarius, S., Franciotta, D., Bergamaschi, R., Wildemann, B. & Wandinger, K. P. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin. Chem. Lab. Med. doi: 10.1515\/CCLM.2010.127.","DOI":"10.1515\/CCLM.2010.127"},{"key":"BFnrneurol201072_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.autrev.2009.04.004","volume":"9","author":"P Saikali","year":"2009","unstructured":"Saikali, P., Cayrol, R. & Vincent, T. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Autoimmun. Rev. 9, 132\u2013135 (2009).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneurol201072_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2009.04.001","volume":"211","author":"T Tani","year":"2009","unstructured":"Tani, T.  et al. Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica. J. Neuroimmunol. 211, 110\u2013113 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201072_CR57","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/glia.20855","volume":"57","author":"GP Nicchia","year":"2009","unstructured":"Nicchia, G. P.  et al. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 57, 1363\u20131373 (2009).","journal-title":"Glia"},{"key":"BFnrneurol201072_CR58","doi-asserted-by":"publisher","first-page":"13609","DOI":"10.1073\/pnas.2235843100","volume":"100","author":"CS Furman","year":"2003","unstructured":"Furman, C. S.  et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc. Natl Acad. Sci. USA 100, 13609\u201313614 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"Suppl. 3","key":"BFnrneurol201072_CR59","first-page":"A119","volume":"72","author":"M Matiello","year":"2009","unstructured":"Matiello, M.  et al. Two different Arg19 mutations in the N-terminus of aquaporin-4 suggest a molecular mechanism for susceptibility to neuromyelitis optica [abstract S17.001]. Neurology 72 (Suppl. 3), A119 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR60","doi-asserted-by":"publisher","first-page":"35850","DOI":"10.1074\/jbc.M109.071670","volume":"284","author":"JM Crane","year":"2009","unstructured":"Crane, J. M., Bennett, J. L. & Verkman, A. S. Live cell analysis of aquaporin-4 M1\/M23 interactions and regulated orthogonal array assembly in glial cells. J. Biol. Chem. 284, 35850\u201335860 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol201072_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius, S.  et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J. Neurol. Sci. 291, 52\u201356 (2010).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201072_CR62","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","volume":"4","author":"F Paul","year":"2007","unstructured":"Paul, F.  et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 4, e133 (2007).","journal-title":"PLoS Med."},{"key":"BFnrneurol201072_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2009.10.002","volume":"217","author":"F Marnetto","year":"2009","unstructured":"Marnetto, F.  et al. Western blot analysis for the detection of serum antibodies recognizing linear aquaporin-4 epitopes in patients with neuromyelitis optica. J. Neuroimmunol. 217, 74\u201379 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201072_CR64","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","volume":"386","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita, M.  et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem. Biophys. Res. Commun. 386, 623\u2013627 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol201072_CR65","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl, M.  et al. Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 66, 630\u2013643 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201072_CR66","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett, J. L.  et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 66, 617\u2013629 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201072_CR67","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","volume":"72","author":"S Nishiyama","year":"2009","unstructured":"Nishiyama, S.  et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72, 1960\u20131961 (2009).","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"BFnrneurol201072_CR68","first-page":"S159","volume":"13","author":"S Jarius","year":"2007","unstructured":"Jarius, S.  et al. Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis [abstract P534]. Mult. Scler. 13 (Suppl. 2), S159 (2007).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/004947559402400211","volume":"24","author":"HA Ahasan","year":"1994","unstructured":"Ahasan, H. A., Rafiqueuddin, A. K., Chowdhury, M. A., Azhar, M. A. & Kabir, F. Neuromyelitis optica (Devic's disease) following chicken pox. Trop. Doct. 24, 75\u201376 (1994).","journal-title":"Trop. Doct."},{"key":"BFnrneurol201072_CR70","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0022-3476(79)80723-4","volume":"95","author":"MJ Chusid","year":"1979","unstructured":"Chusid, M. J., Williamson, S. J., Murphy, J. V. & Ramey, L. S. Neuromyelitis optica (Devic disease) following varicella infection. J. Pediatr. 95, 737\u2013738 (1979).","journal-title":"J. Pediatr."},{"key":"BFnrneurol201072_CR71","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2796.2007.01794.x","volume":"261","author":"C Tran","year":"2007","unstructured":"Tran, C.  et al. Neuromyelitis optica following CMV primo-infection. J. Intern. Med. 261, 500\u2013503 (2007).","journal-title":"J. Intern. Med."},{"key":"BFnrneurol201072_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","volume":"251","author":"A Ghezzi","year":"2004","unstructured":"Ghezzi, A.  et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J. Neurol. 251, 47\u201352 (2004).","journal-title":"J. Neurol."},{"key":"BFnrneurol201072_CR73","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","volume":"68","author":"S Jarius","year":"2007","unstructured":"Jarius, S.  et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68, 1076\u20131077 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(06)70333-7","volume":"5","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker, B. G., Wingerchuk, D. M., Nakashima, I., Fujihara, K. & Lennon, V. A. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol. 5, 110\u2013111 (2006).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201072_CR75","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/brain\/awm027","volume":"130","author":"T Matsuoka","year":"2007","unstructured":"Matsuoka, T.  et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130, 1206\u20131223 (2007).","journal-title":"Brain"},{"key":"BFnrneurol201072_CR76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1620\/tjem.210.307","volume":"210","author":"T Takahashi","year":"2006","unstructured":"Takahashi, T.  et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J. Exp. Med. 210, 307\u2013313 (2006).","journal-title":"Tohoku J. Exp. Med."},{"key":"BFnrneurol201072_CR77","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","volume":"77","author":"I Nakashima","year":"2006","unstructured":"Nakashima, I.  et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatry 77, 1073\u20131075 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201072_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"A Petzold","year":"2010","unstructured":"Petzold, A.  et al. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J. Neurol. Neurosurg. Psychiatry 81, 109\u2013111 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201072_CR79","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1136\/jnnp.2008.145391","volume":"79","author":"T Takahashi","year":"2008","unstructured":"Takahashi, T.  et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J. Neurol. Neurosurg. Psychiatry 79, 1075\u20131078 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201072_CR80","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock, S. J.  et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch. Neurol. 63, 964\u2013968 (2006).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201072_CR81","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","volume":"72","author":"SM Magana","year":"2009","unstructured":"Magana, S. M.  et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72, 712\u2013717 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR82","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0b013e3181bd6a85","volume":"73","author":"S Ito","year":"2009","unstructured":"Ito, S. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 73, 1604 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","volume":"71","author":"A McKeon","year":"2008","unstructured":"McKeon, A.  et al. CNS aquaporin-4 autoimmunity in children. Neurology 71, 93\u2013100 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR84","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/art.27337","volume":"62","author":"KP Wandinger","year":"2010","unstructured":"Wandinger, K. P.  et al. Autoantibodies against aquaporin-4 in patients with neuropsychiatric SLE and primary Sj\u00f6gren\u00b4s syndrome. Arthritis Rheum. 62, 1198\u20131200 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrneurol201072_CR85","first-page":"78","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock, S. J.  et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch. Neurol. 65, 78\u201383 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201072_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","volume":"196","author":"S Hayakawa","year":"2008","unstructured":"Hayakawa, S.  et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J. Neuroimmunol. 196, 181\u2013187 (2008).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201072_CR87","first-page":"629","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock, S. J. & Lennon, V. A. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch. Neurol. 65, 629\u2013632 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201072_CR88","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ana.10587","volume":"54","author":"SA Cross","year":"2003","unstructured":"Cross, S. A.  et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann. Neurol. 54, 38\u201350 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201072_CR89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","volume":"78","author":"F Ducray","year":"2007","unstructured":"Ducray, F.  et al. Devic's syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies. J. Neurol. Neurosurg. Psychiatry 78, 325\u2013327 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201072_CR90","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1212\/01.wnl.0000345066.57745.50","volume":"72","author":"EC Klawiter","year":"2009","unstructured":"Klawiter, E. C.  et al. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 72, 1101\u20131103 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR91","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-2002-36534","volume":"22","author":"BA Cree","year":"2002","unstructured":"Cree, B. A., Goodin, D. S. & Hauser, S. L. Neuromyelitis optica. Semin. Neurol. 22, 105\u2013122 (2002).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol201072_CR92","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1073\/pnas.0902725106","volume":"106","author":"JD Ho","year":"2009","unstructured":"Ho, J. D.  et al. Crystal structure of human aquaporin 4 at 1.8\u00a0\u00c5 and its mechanism of conductance. Proc. Natl Acad. Sci. USA 106, 7437\u20137442 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201072_CR93","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2105-6-21","volume":"6","author":"JL Moreland","year":"2005","unstructured":"Moreland, J. L., Gramada, A., Buzko, O. V., Zhang, Q. & Bourne, P. E. The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinformatics 6, 21 (2005).","journal-title":"BMC Bioinformatics"},{"key":"BFnrneurol201072_CR94","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1590\/S0004-282X2008000300001","volume":"66","author":"T Adoni","year":"2008","unstructured":"Adoni, T., Lino, A. M., Marchiori, P. E., Kok, F. & Callegaro, D. Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica. Arq. Neuropsiquiatr. 66, 295\u2013297 (2008).","journal-title":"Arq. Neuropsiquiatr."},{"key":"BFnrneurol201072_CR95","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/1352458507084595","volume":"14","author":"R Marignier","year":"2008","unstructured":"Marignier, R.  et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult. Scler. 14, 440\u2013445 (2008).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201072_CR96","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","volume":"254","author":"A Saiz","year":"2007","unstructured":"Saiz, A.  et al. Revised diagnostic criteria for neuromyelitis optica (NMO): application in a series of suspected patients. J. Neurol. 254, 1233\u20131237 (2007).","journal-title":"J. Neurol."},{"key":"BFnrneurol201072_CR97","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","volume":"256","author":"E Bizzoco","year":"2009","unstructured":"Bizzoco, E.  et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J. Neurol. 256, 1891\u20131898 (2009).","journal-title":"J. Neurol."},{"key":"BFnrneurol201072_CR98","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485\u20131489 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol201072_CR99","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1373\/clinchem.2008.116848","volume":"55","author":"M Apiwattanakul","year":"2009","unstructured":"Apiwattanakul, M.  et al. AQP4-IgG immunoprecipitation assay optimization. Clin. Chem. 55, 592\u2013594 (2009).","journal-title":"Clin. Chem."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2010.72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2010.72","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2010.72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:59:02Z","timestamp":1684472342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2010.72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFnrneurol201072"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2010.72","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}